Georgia Limits OTC Pseudoephedrine Sales To Pharmacies
This article was originally published in The Tan Sheet
Executive Summary
Georgia lawmakers approve a new tactic to prevent the diversion of OTC pseudoephedrine products to making methamphetamine – limiting sales to pharmacies.
You may also be interested in...
Indiana Ups State Power To Limit Pseudoephedrine Product Sales
DEA has the authority and expertise to conduct stress tests on pseudoephedrine formulations, says CHPA state government director Carol Gutierrez. But Indiana allows its pharmacy board to say whether a PSE product is tamper-resistant.
Indiana Ups State Power To Limit Pseudoephedrine Product Sales
DEA has the authority and expertise to conduct stress tests on pseudoephedrine formulations, says CHPA state government director Carol Gutierrez. But Indiana allows its pharmacy board to say whether a PSE product is tamper-resistant.
States Modify PSE Rx-Only Proposals To Curb Meth Production
Legislators in Kentucky debate requiring a prescription for purchase of OTC pseudoephedrine over monthly and annual limits, while Oklahoma lawmakers consider requiring pharmacists to determine a patient’s need. CHPA opposes further limits on access and promotes electronic tracking with stop-sale technology.